Mechanistic targets for BPH and prostate cancer-a review

Abhishek Shah, Aarti Abhishek Shah, K. Nandakumar, Richard Lobo

Research output: Contribution to journalArticlepeer-review

Abstract

All men, almost, suffer from prostatic disorders in average life expectancy. In the year of 1950s, the first autopsy of prostate gland discovered the link between Benign prostatic hyperplasia (BPH) and Prostate Cancer (PCa). After that, many histology, biochemistry, epidemiology studies explained the association and associated risk factor for the same. From the various scientific evidence, it is proved that both diseases share some common transcription factors and signalling pathways. Still, BPH cannot be considered as the first step of PCa progression. To define, the relationship between both of the diseases, a well-defined large epidemiological study is needed. Along with androgen signalling, imbalanced apoptosis, oxidative stress, and microbial infection also crucial factors that significantly affect the pathogenesis of BPH. Various signalling pathways are involved in the progression of BPH. Androgen signalling is the driving force for the progress of PCa. In PCa androgen signalling is upregulated as compared to a healthy prostate. Some dominant Androgen-regulated genes and their functions have been discussed in this work.

Original languageEnglish
JournalReviews on Environmental Health
DOIs
Publication statusAccepted/In press - 2020

All Science Journal Classification (ASJC) codes

  • Health(social science)
  • Pollution
  • Public Health, Environmental and Occupational Health

Fingerprint Dive into the research topics of 'Mechanistic targets for BPH and prostate cancer-a review'. Together they form a unique fingerprint.

Cite this